4.7 Article

Enhancement of Attentional Performance by Selective Stimulation of α4β2*nAChRs: Underlying Cholinergic Mechanisms

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 35, Issue 6, Pages 1391-1401

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2010.9

Keywords

nicotine; S 38232; methyllycaconitine; attention; acetylcholine; cognition

Funding

  1. PHS [MH080426, MH080332, T32 DA007267]
  2. Institut de Recherches Internationales Servier (Courbevoie, France)

Ask authors/readers for more resources

Impairments in attention are a major component of the cognitive symptoms of neuropsychiatric and neurodegenerative disorders. Using an operant sustained attention task (SAT), including a distractor condition (dSAT), we assessed the putative pro-attentional effects of the selective alpha 4 beta 2* nicotinic acetylcholine receptor (nAChR) agonist S 38232 in comparison with the non-selective agonist nicotine. Neither drug benefited SAT performance. However, in interaction with the increased task demands implemented by distractor presentation, the selective agonist, but not nicotine, enhanced the detection of signals during the post-distractor recovery period. This effect is consistent with the hypothesis that second-long increases in cholinergic activity ('transients') mediate the detection of cues and that nAChR agonists augment such transients. Electrochemical recordings of prefrontal cholinergic transients evoked by S 38232 and nicotine indicated that the alpha 4 beta 2* nAChR agonist evoked cholinergic transients that were characterized by a faster rise time and more rapid decay than those evoked by nicotine. Blockade of the alpha 7 nAChR 'sharpens' nicotine-evoked transients; therefore, we determined the effects of co-administration of nicotine and the alpha 7 nAChR antagonist methyllycaconitine on dSAT performance. Compared with vehicle and nicotine alone, this combined treatment significantly enhanced the detection of signals. These results indicate that compared with nicotine, alpha 4 beta 2* nAChR agonists significantly enhance attentional performance and that the dSAT represents a useful behavioral screening tool. The combined behavioral and electrochemical evidence supports the hypothesis that nAChR agonist-evoked cholinergic transients, which are characterized by rapid rise time and fast decay, predict robust drug-induced enhancement of attentional performance. Neuropsychopharmacology (2010) 35, 1391-1401; doi: 10.1038/npp.2010.9; published online 10 February 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available